Does sTNF-R1 predict mortality in patients with chronic heart failure?
sTNF-R1 may be a useful biomarker for identifying high-risk chronic heart failure patients and monitoring anti-TNF-alpha treatment.
sTNF-R1 was the strongest and most accurate prognosticator, independent of established markers of CHF severity. Assessment of sTNF-R1 may be useful in identifying patients who are at high risk of death and in monitoring patients undergoing anti-TNF-alpha treatment.
Rauchhaus et al. (Tue,) studied this question.